Salmonella Typhi TY2 Vi Polysaccharide Antigen Uses, Dosage, Side Effects and more

Salmonella Typhi TY2 Vi Polysaccharide Antigen is a vaccine that is administered intramuscularly. It is an active immunization for the prevention of typhoid fever caused by S typhi and is approved for use in persons two years of age or older. The vaccine contains the purified cell surface Vi polysaccharide extracted from Salmonella enterica serovar Typhi, S typhi Ty2 strain. The bacterial culture is inactivated in the medium with the capsular polysaccharides precipated from the solution.

Trade Name Salmonella Typhi TY2 Vi Polysaccharide Antigen
Generic Typhoid Vi polysaccharide vaccine
Typhoid Vi polysaccharide vaccine Other Names Salmonella typhi TY2 Vi polysaccharide antigen, Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain
Type
Groups Approved
Therapeutic Class
Manufacturer
Available Country
Last Updated: January 7, 2025 at 1:49 am

Innovators Monograph

*** Taking medicines without doctor's advice can cause long-term problems.
Share